In addition, elevated levels of TNF-α, IL-6 and MCP-1 were associated with the development of NAFLD, and pharmacological and genetic inhibition of these pro-inflammatory mediators ameliorated hepatic steatosis in obese animals [2,31]. The gene discussed is CCL2; the disease is Hepatic steatosis.